title: [Postpartum psychosis associated with cabergoline].
authors: Alejandro
authors: A
authors: Salinas Botrán
authors: Diego
authors: D
authors: Urgelés Puértolas
authors: Elena
authors: E
authors: Peregrin Abad
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000077465:Cabergoline; D002585:Cesarean Section; D018491:Dopamine Agonists / Q000009:adverse effects*; D004873:Ergolines / Q000009:adverse effects*; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007774:Lactation / Q000187:drug effects; D011183:Postoperative Complications / Q000139:chemically induced / Q000523:psychology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000523:psychology; D059285:Pregnancy, Twin; D011595:Psychomotor Agitation / Q000209:etiology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology*; D011644:Puerperal Disorders / Q000139:chemically induced* / Q000188:drug therapy; D018967:Risperidone / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced
chemical_list: D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D004873:Ergolines; D018967:Risperidone; D000077465:Cabergoline